Home  >  Products  >  RDH13 (retinol dehydrogenase 13 (all-trans/9-cis) ) Blocking Peptide (the C terminal of RDH13)(100ug)
RDH13 (retinol dehydrogenase 13 (all-trans/9-cis) ) Blocking Peptide (the C terminal of RDH13)(100ug)

RDH13 (retinol dehydrogenase 13 (all-trans/9-cis) ) Blocking Peptide (the C terminal of RDH13)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-RDH13 Antibody (ARP62403_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP62403
Size: 100ug
Weight: 36kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: This gene encodes a mitochondrial short-chain dehydrogenase/reductase, which catalyzes the reduction and oxidation of retinoids. The encoded enzyme may function in retinoic acid production and may also protect the mitochondria against oxidative stress. Alternatively spliced transcript variants have been described.
Alternative names: DKFZp313H0740; FLJ39479; SDR7C3
See Full Product Listings >